Turn Complex Healthcare Stories into Capital Markets Confidence
Trusted by 550+ life sciences companies since 1997
Dedicated IR and capital markets communications for healthcare innovators, from IPO prep to mature public companies.
Healthcare is different. Regulatory constraints, clinical milestones, payer dynamics, scientific complexity, and the constant need to raise capital demand IR advisors who live in this world every day.
A Proven Healthcare IR Partner
for Complex, High-Stakes Moments:
Deep expertise across biotech, pharma, medtech, services, and diagnostics with over 550 engagements since 1997.
Clients range from microcaps to S&P 500, Fortune 500, and NASDAQ 100
Global footprint supporting U.S., international, and cross-border mandates.
Support full corporate lifecycle, including pre-IPO positioning, IPO readiness, secondary offerings, M&A, strategic reviews, restructurings, and more.
Deep experience translating clinical trial results, regulatory developments, reimbursement, and pipeline milestones into clear, investor‑ready narratives that resonate with the market.
Every engagement is led by senior professionals with substantial healthcare experience, giving clients direct access to seasoned advisors.
Trusted by healthcare executives who return to us repeatedly, with some client relationships re-engaging up to four times.
We understand the challenges many healthcare companies face:
01
Strong clinical or operational progress not reflected in valuation.
02
Differentiating the technology and positioning the data against commercial and would-be competitors.
03
Inappropriate investor meetings; wrong funds in the room.
04
Limited internal bandwidth to build and sustain a disciplined IR program.
The outcome our IR programs help deliver:
A clear, differentiated equity story tailored for target investors.
Consistent messaging across earnings, presentations, press releases and investor conversations, as well as SEC filings.
Stronger investor base over time – better fit, sharper questions, less noise.
Board‑ready IR strategy and analytics to support major decisions.
Services
IR strategy, goals, and annual planning
Investor and analyst targeting, proactive outreach, and tracking
Support for transactions, fundraisings and business pivots
Equity story development for healthcare investors and generalists
Validation and expert commentary through KOLs
Investor presentations, fact sheets, IR website content, and earnings support
Clinical, regulatory and reimbursement milestone communications
Translation of complex science and development pathways
Crisis and issue communications (safety signals, data readouts, reimbursement changes, regulatory delays)
Market perception and peer intelligence
Shareholder base and trading diagnostics
Board and management coaching for investor communication
Ready to get started?
Fill out this form to request a brief call with our team. Let’s explore how our Healthcare Industry Practice can support your IR objectives, and drive long‑term shareholder value.
800 Third Avenue, 17th Floor
New York, NY 10022
United States
